Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LHC Group, IncLHCG · Entity 116591 | Director | March 01, 2018 | March 05, 2018 |
| Sanara MedTech Inc.SMTI · Entity 5880 | Director | July 07, 2022 | July 08, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LHC Group, Inc
Report date March 01, 2018 · Filed March 05, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,550 |
Reported balance
After 2018-03-01 transaction · row 1
1 source rowRow 1 · 2018-03-01 · Grant · Acquired 1,700 · Balance 20,550 F1: Restricted stock granted pursuant to the 2005 Non-Employee Director Compensation Plan, which vests on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock granted pursuant to the 2005 Non-Employee Director Compensation Plan, which vests on the first anniversary of the grant date.
Sanara MedTech Inc.
Report date July 07, 2022 · Filed July 08, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,945 |
Reported balance
After 2022-07-07 transaction · row 1
1 source rowRow 1 · 2022-07-07 · Grant · Acquired 5,027 · Balance 16,945 F1: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 10, 2023, provided that the reporting person is providing certain services to the Company on such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 10, 2023, provided that the reporting person is providing certain services to the Company on such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 07, 2022 Filed Jul 8, 2022 22:02 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 5,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-018954 · ownership.xml · nonDerivative · entry 1 Thorpe Kenneth E · CIK 0001482846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,945 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 10, 2023, provided that the reporting person is providing certain services to the Company on such date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:52 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 2,337 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-004130 · ownership.xml · nonDerivative · entry 3 Thorpe Kenneth E · CIK 0001482846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,918 F2 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the date of the Company's 2022 annual meeting of shareholders; provided that the reporting person is providing services to the Company until such date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:52 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 4,887 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-004130 · ownership.xml · nonDerivative · entry 2 Thorpe Kenneth E · CIK 0001482846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,581 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. All of the shares of restricted stock vested on February 9, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:52 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 2,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-004130 · ownership.xml · nonDerivative · entry 1 Thorpe Kenneth E · CIK 0001482846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,694 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. All of the shares of restricted stock vested on February 9, 2022. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 17:00 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 2,410 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000056 · edgar.xml · nonDerivative · entry 1 Thorpe Kenneth E · CIK 0001482846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,410 Read SEC document |
| February 10, 2020 Filed Feb 10, 2020 23:43 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | OtherCommon Stock | 2,410 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897423-20-000026 · edgar.xml · nonDerivative · entry 1 Thorpe Kenneth E · CIK 0001482846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 2,410 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock. F1 · price: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 2,410 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 22:04 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 2,410 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000020 · edgar.xml · nonDerivative · entry 1 Thorpe Kenneth E · CIK 0001482846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,410 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 16:49 UTC | LHC Group, Inc LHCG · Entity 116591 | GrantCommon Stock | 1,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001303313-18-000017 · wf-form4_152028654120776.xml · nonDerivative · entry 1 Thorpe Kenneth E · CIK 0001482846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,550 F1 · kind: Restricted stock granted pursuant to the 2005 Non-Employee Director Compensation Plan, which vests on the first anniversary of the grant date. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:05 UTC | LHC Group, Inc LHCG · Entity 116591 | GrantCommon Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001303313-17-000021 · wf-form4_148857871133694.xml · nonDerivative · entry 1 Thorpe Kenneth E · CIK 0001482846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,850 F1 · kind: Restricted stock granted pursuant to the 2005 Non-Employee Director Compensation Plan, which vests on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.